Moderator: Noopur Raje, MD (Massachusetts General Hospital)
Panelists:
Reena Jayani-Kosarzycki, MD (Vanderbilt University Medical Center)
Andrew Kuykendall, MD (Moffitt Cancer Center)
Oreofe Odejide, MD, MPH (Harvard Medical School)
Neil Palmisiano, MD, MS (Rutgers Cancer Institute)
Sarah Rutherford, MD (Weill Cornell Medicine)
Sponsored by Pfizer
8:30 AM
Opening & Welcome by Chairs
Joanna Rhodes, MD, MSCE (Rutgers Cancer Institute of New Jersey)
Jesús Berdeja, MD (Greco-Hainsworth Tennessee Oncology Centers for Research)
8:45 AM
Chronic Lymphocytic Leukemia
Inhye Ahn, MD (Harvard Medical School)
9:00 AM
Indolent Lymphomas
Ryan Jacobs, MD (Atrium Health Levine Cancer Institute)
9:15 AM
Aggressive Lymphomas
Matthew Lunning, DO, FACP (University of Nebraska)
9:30 AM
Hodgkin Lymphoma
Boyu Hu, MD (University of Utah Health)
9:45 AM
Panel Discussion + Q&A
10:45 AM
Myeloproliferative Neoplasms and Myelodysplastic Syndrome
Hetty Carraway, MD, MBA (Cleveland Clinic)
11:00 AM
Acute Leukemias
Neil Palmisiano, MD, MS (Rutgers Cancer Institute)
11:15 AM
Multiple Myeloma
Peter Voorhees, MD (Atrium Health Levine Cancer Institute)
11:30 AM
Debate: Is Transplant Still the Best Option for All Eligible Patients?
Amrita Krishnan, MD, FACP (City of Hope)
Natalie Callander, MD (University of Wisconsin)
Moderator: Rahul Banerjee, MD, FACP (Fred Hutch Cancer Center)
11:55 AM
Panel Discussion + Q&A
1:35 PM
Myeloproliferative Neoplasms
John Mascarenhas, MD (Mount Sinai Health System)
1:50 PM
Myelodysplastic Syndrome
Amer Zeidan, MBBS (Yale Cancer Center)
2:05 PM
Multiple Myeloma: Early Relapse
Joshua Richter, MD, FACP (Mount Sinai Health System)
2:20 PM
Debate: Should CAR-T be Used for 2nd Line Therapy?
Krina Patel, MD, MSc (MD Anderson Cancer Center)
Caitlin Costello, MD (University of California San Diego)
Moderator: Rahul Banerjee, MD, FACP (Fred Hutch Cancer Center)
2:45 PM
Panel Discussion + Q&A
3:45 PM
Optimal Sequencing in Chronic Lymphocytic Leukemia
Callie Coombs, MD (University of California-Irvine)
4:00 PM
Indolent Lymphomas
Carla Casulo, MD (James P. Wilmot Cancer Institute)
4:15 PM
Hodgkin Lymphoma
Jakub Svoboda, MD (University of Pennsylvania)
4:30 PM
Aggressive Lymphomas
Tycel Phillips, MD (City of Hope)
4:45 PM
Panel Discussion + Q&A
8:40 AM
Managing Cytokine Release Syndrome in the Community
Oreofe Odejide, MD, MPH (Harvard Medical School)
8:55 AM
Managing Neurotoxicity in the Community
Yi Lin, MD, PhD (Mayo Clinic)
9:10 AM
Preventing and Managing Infections
Noopur Raje, MD (Massachusetts General Hospital)
9:25 AM
Integrating Bispecifics into Practice
Jonathan Abbas, MD (Tennessee Oncology)
9:40 AM
Question & Answer
10:25 AM
Indolent Lymphomas (including Chronic Lymphocytic Leukemia)
Alan Skarbnik, MD (Novant Health Cancer Institute)
10:40 AM
Aggressive Lymphomas
Mazyar Shadman, MD, MPH (Fred Hutch Cancer Center)
10:55 AM
Multiple Myeloma: Later Relapse
Susan Bal, MD (University of Alabama Birmingham)
11:10 AM
Debate: Later Relapse in MM: CAR-T vs. Bispecifics
Sham Mailankody, MBBS (Memorial Sloan Kettering Cancer Center)
Ajai Chari, MD (University of California San Francisco)
Moderator: Rahul Banerjee, MD, FACP (Fred Hutch Cancer Center)
11:35 AM
Panel Discussion + Q&A
1:15 PM
Healthcare Policy
Stephen Schleicher, MD, MBA (Tennessee Oncology)
1:30 PM
Measurable Residual Disease in Hematologic Malignancies
Hearn Cho, MD, PhD (Mount Sinai Health System)
1:45 PM
Defining High Risk Disease in Hematologic Malignancies
Faith Davies, MD, MBBCh (NYU Langone Health)
2:00 PM
Dealing with Drug Shortages in Oncology
Jason Westin, MD (MD Anderson Cancer Center)
2:15 PM
Diversity, Equity, and Inclusion in Hematologic Malignancies
Christopher Flowers, MD, MS (MD Anderson Cancer Center)
2:30 PM
Bringing CAR-T to the Community
Natalie Dickson, MD, MMHC, FACP (Tennessee Oncology)
2:45 PM
Question & Answer
3:30 PM
Multiple Myeloma
Adam Cohen, MD (University of Pennsylvania)
3:45 PM
Chronic Lymphocytic Leukemia
Jacqueline Barrientos, MD, MS (Mount Sinai Health System)
4:00 PM
Indolent Lymphomas
Elise Chong, MD (University of Pennsylvania)
4:15 PM
Aggressive Lymphomas
Sarah Rutherford, MD (Weill Cornell Medicine)
4:30 PM
Myeloproliferative Neoplasms and Myelodysplastic Syndrome
Andrew Kuykendall, MD (Moffitt Cancer Center)
4:45 PM
Acute Leukemias
Alexander Perl, MD (University of Pennsylvania)
*Agenda is subject to change.
Experience Nashville, TN
